Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psoriasis and filariasis.
Osamulia-Soendjojo N, Prens EP, Sluiters JF, Naafs B. Osamulia-Soendjojo N, et al. Among authors: prens ep. Br J Dermatol. 1994 Nov;131(5):723-4. Br J Dermatol. 1994. PMID: 7999612 No abstract available.
Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dutch Society of Dermatology and Venereology.
Zweegers J, de Jong EM, Nijsten TE, de Bes J, te Booij M, Borgonjen RJ, van Cranenburgh OD, van Deutekom H, van Everdingen JJ, de Groot M, Van Hees CL, Hulshuizen H, Koek MB, de Korte WJ, de Korte J, Lecluse LL, Pasch MC, Poblete-Gutiérrez PA, Prens EP, Seyger MM, Thio HB, Torcque LA, de Vries AC, van de Kerkhof PC, Spuls PI. Zweegers J, et al. Among authors: prens ep. Dermatol Online J. 2014 Mar 17;20(3):doj_21769. Dermatol Online J. 2014. PMID: 24656281 Free article.
Regulated genes in psoriatic skin during treatment with fumaric acid esters.
Onderdijk AJ, Balak DM, Baerveldt EM, Florencia EF, Kant M, Laman JD, van IJcken WF, Racz E, de Ridder D, Thio HB, Prens EP. Onderdijk AJ, et al. Among authors: prens ep. Br J Dermatol. 2014 Oct;171(4):732-41. doi: 10.1111/bjd.13128. Epub 2014 Sep 30. Br J Dermatol. 2014. PMID: 24852654
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J, Rissmann R. Balak DM, et al. Among authors: prens ep. Clin Immunol. 2017 Jan;174:63-72. doi: 10.1016/j.clim.2016.09.015. Epub 2016 Nov 20. Clin Immunol. 2017. PMID: 27876460 Clinical Trial.
244 results